| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |